LTR Pharma Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	34.07	3.1	1.73	1.91	0.15
Cash & Short-Term Investments	34.07	3.1	1.73	1.91	0.15
Cash Growth	465.99%	79.46%	-9.56%	1205.48%	-
Other Receivables	0.58	0.27	0.06	0.04	-
Receivables	0.59	0.27	0.06	0.04	-
Total Current Assets	34.66	3.37	1.79	1.95	0.15
Property, Plant & Equipment	0.01	0	-	-	-
Other Long-Term Assets	0.06	-	-	-	0
Total Assets	34.73	3.37	2.09	2.25	0.42
Accounts Payable	0.26	0.24	0.01	0.47	0
Accrued Expenses	0.12	0.13	0.01	0.01	0
Short-Term Debt	-	-	-	-	0.36
Other Current Liabilities	0.06	0.06	-	-	0.1
Total Current Liabilities	0.43	0.43	0.02	0.48	0.46
Total Liabilities	0.43	0.43	0.02	0.48	0.46
Common Stock	44.11	10.74	4.53	2.79	-
Retained Earnings	-11.88	-9.48	-2.52	-1.07	-0.04
Comprehensive Income & Other	2.07	1.67	0.07	0.04	-
Shareholders' Equity	34.3	2.94	2.07	1.77	-0.04
Total Liabilities & Equity	34.73	3.37	2.09	2.25	0.42
Total Debt	-	-	-	-	0.36
Net Cash (Debt)	34.07	3.1	1.73	1.91	-0.21
Net Cash Growth	465.99%	79.46%	-9.56%	-	-
Net Cash Per Share	0.23	0.02	0.01	-	-
Filing Date Shares Outstanding	180.98	153.8	414.9	-	-
Total Common Shares Outstanding	180.98	139.42	414.9	-	-
Working Capital	34.23	2.94	1.77	1.48	-0.32
Book Value Per Share	0.19	0.02	0.00	-	-
Tangible Book Value	34.3	2.94	2.07	1.77	-0.04
Tangible Book Value Per Share	0.19	0.02	0.00	-	-

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.